Companies Dominating the In-vivo Imaging Landscape
- PerkinElmer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bruker
- FUJIFILM VisualSonics Inc.
- Siemens
- Miltenyi Biotec
- CMR Naviscan
- SCANCO Medical AG
- Aspect Imaging Ltd.
- Mediso Ltd.
- LI-COR, Inc.
- MILabs B.V.
- MR Solutions
- Trifoil Imaging
- Biospace Lab
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of in-vivo imaging is estimated at USD 1.21 billion.
The in-vivo imaging market size was over USD 1.15 billion in 2024 and is poised to cross USD 2.64 billion by the end of 2037, growing at more than 6.6% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of cancer across the globe and the rising trend of precision medicine will drive the market growth.
Asia Pacific industry is set to account for largest revenue share 46% by 2037, impelled by increasing spending in healthcare in the region.
The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.
